Clinical phase I/II trial to investigate neoadjuvant intensity-modulated short term radiation therapy (5 × 5 gy) and intraoperative radiation therapy (15 gy) in patients with primarily resectable pancreatic cancer - NEOPANC

BACKGROUND: The current standard treatment, at least in Europe, for patients with primarily resectable tumors, consists of surgery followed by adjuvant chemotherapy. But even in this prognostic favourable group, long term survival is disappointing because of high local and distant failure rates. Pos...

Descripción completa

Detalles Bibliográficos
Autores principales: Roeder, Falk, Timke, Carmen, Saleh-Ebrahimi, Ladan, Schneider, Lutz, Hackert, Thilo, Hartwig, Werner, Kopp-Schneider, Annette, Hensley, Frank W, Buechler, Markus W, Debus, Juergen, Huber, Peter E, Werner, Jens
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2012
Materias:
Study Protocol
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3323416/
https://www.ncbi.nlm.nih.gov/pubmed/22443802
http://dx.doi.org/10.1186/1471-2407-12-112

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3323416/
https://www.ncbi.nlm.nih.gov/pubmed/22443802
http://dx.doi.org/10.1186/1471-2407-12-112

Ejemplares similares